Panzem NCD 2-methoxyestradiol: Phase Ib started

ENMD began an open-label, U.S. Phase Ib trial in patients with stage IV or inoperable stage III breast cancer with Panzem in combination with Taxol paclitaxel from Bristol-Myers Squibb Co. (BMY, New...